Biologics CDMO | BioXcellence | Boehringer Ingelheim

Boehringer Ingelheim BioXcellence™

We’re your trusted end‑to‑end contract manufacturing partner for mammalian and microbial technologies.

Bringing your biologics to life.

At Boehringer Ingelheim BioXcellence™, we specialize in biologics contract manufacturing, producing biopharmaceuticals based on microorganisms as well as mammalian cell cultures. In collaboration with our partners, we manufacture innovative therapies for some of the world’s most challenging diseases.

What makes us special: We’re a true biopharma CDMO.

40+ years of biotechnology experience

reliably turning your biologic innovation into commercial success

49 commercialized biopharmaceuticals

brought to market together with our partners

4 global biopharma manufacturing sites

strategically located in the U.S., Germany, Austria and China

30+ global, long-standing customers

7 of the Top 10 pharma companies (by sales) trust our expertise

What we do: end‑to‑end global CDMO services for your late-stage biopharmaceuticals.

Mammalian manufacturing

Microbial manufacturing

Aseptic filling

Webinar: When Biologics Supply Can’t Fail – How Sponsors Should Evaluate Manufacturing Resilience

Register here

Our site in Fremont, California, USA

At our plant in the San Francisco Bay Area, we operate two flexible cell culture and purification trains for simultaneous large-scale biopharmaceutical contract manufacturing. The facility is dedicated to producing monoclonal antibodies and other proteins from mammalian cell culture technology.

[Read more](/content/partnering/boehringer-ingelheim-bioxcellence/newsroom/fremont-spotlight-bioxcellence "Read more"/index.html)

Tech transfer and process optimization

In technology transfers we balance speed and risk across mammalian cell culture and microbial technologies, supporting process optimization and scale-up for late-stage clinical supply of biologics and like-to-like transfers of commercial products.

[Read more](/content/partnering/boehringer-ingelheim-bioxcellence/newsroom/technology-transfer-bioxcellence "Tech transfer and process optimization"/index.html)

Launch preparation, manufacturing and commercial supply

Backed by long-standing scientific, regulatory and biopharma manufacturing expertise and a global network of customer-centric teams, we help de-risk launch and support reliable commercial supply of biologics throughout the product life cycle.

[Read more](/content/partnering/boehringer-ingelheim-bioxcellence/our-global-network "Launch preparation, manufacturing and commercial supply"/index.html)

Aseptic fill/finish

Our aseptic filling services for liquid and lyophilized vials support late-stage clinical-to-commercial biologics supply and global distribution. With flexible batch sizes and vial formats, we can adapt to changing demands without compromising quality or patient safety.

[Read more](/content/partnering/boehringer-ingelheim-bioxcellence/newsroom/aseptic-filling-bioxcellence "Aseptic fill/finish"/index.html)

Why partner with Boehringer Ingelheim BioXcellence™

With over 40 years of biotechnology expertise and a global network of biopharma manufacturing facilities, we’ve helped bring more than 45 therapies to patients worldwide. Our experience in contract manufacturing makes us a trusted partner in turning biologic innovations into commercial successes.

Over 40 years of experience

A track record of 49 commercialized products and decades of experience proves that our know-how can be to your advantage.

[Read more about our biotech story](/content/partnering/boehringer-ingelheim-bioxcellence/newsroom/our-biotech-story-bioxcellence "Over 40 years of experience"/index.html)

49 biopharmaceuticals brought to market together with our partners

Whether you're scaling up, navigating regulatory complexities, or looking for reliable supply, our team of experts is here to make it happen.

[Read more about how you can connect with our team](/content/partnering/boehringer-ingelheim-bioxcellence/contact-bioxcellence "49 biopharmaceuticals brought to market together with our partners"/index.html)

4 biopharma sites across the world

Our multi-product manufacturing facilities in the U.S., Germany, China, and Austria offer tailored, end-to-end contract manufacturing services.

[Read more about our global network](/content/partnering/boehringer-ingelheim-bioxcellence/our-global-network "4 biopharma sites across the world"/index.html)

~ 460,000 L commercial capacity for mammalian cell culture manufacturing

Your cell culture-based biologics deserve the best care – and we’re here to provide a nurturing environment for them to thrive.

[Read more about our mammalian expertise](/content/partnering/boehringer-ingelheim-bioxcellence/mammalian-expertise "~ 430,000 L commercial capacity for mammalian cell culture manufacturing"/index.html)

12,000 L commercial capacity for microbial technologies

We’re proud of our experience with diverse molecule formats manufactured in E. coli and yeast systems.

[Read more about our microbial expertise](/content/partnering/boehringer-ingelheim-bioxcellence/microbial-expertise "12,000 L commercial capacity for microbial technologies"/index.html)

7 of the Top 10 pharma companies trust us for our commercialization experience

We’re a trusted partner for companies worldwide and have earned a reputation as a reliable contract manufacturing organization (CMO).

Headline source: Evaluate Ltd. – Top 50 global Pharmaceutical Company Rx Sales Report 2025

[Read more about the international recognition we’ve received](/content/partnering/boehringer-ingelheim-bioxcellence/newsroom/awards-certifications-bioxcellence "7 of the Top 10 pharma companies trust us for our commercialization experience"/index.html)

State-of-the-art facilities

Bioprocesses are complex, but through our facility setup and expertise we're making them smarter. Digital twins allow us to test and simulate new technologies or process variants in a virtual environment.

[Read more in our whitepaper](/content/partnering/boehringer-ingelheim-bioxcellence/newsroom/biopharma-plant-process-modeling-bioxcellence "State-of-the-art facilities"/index.html)

“At Boehringer Ingelheim BioXcellence™, trust and reliability aren’t just promises – they’re the foundation of everything we do. As part of a 140-year-old independent biopharmaceutical company, we bring high ethical standards and a commitment to transforming lives for generations. Our global manufacturing network offers flexibility, seamless support, and peace of mind for our customers and their patients. We don’t just deliver solutions, we deliver confidence.”

Andrea Rothmaler

Head of Boehringer Ingelheim BioXcellence™

Upcoming events and conferences

Meet the Boehringer Ingelheim BioXcellence™ team at major bioprocessing, biomanufacturing and biopharma partnering conferences and exhibitions this year. Here's where we're going to next – ready to discuss how we can turn your scientific discoveries into real-world solutions together:

BioProcess International (BPI)

September 22-25, 2026

Boston, MA, USA

Learn more

CPHI Milan

October 6-8, 2026

Fiera Milano, Italy

Learn more

CDMO Live Americas

Oct 20-21, 2026

Boston, MA, USA

Learn more

Press releases from Boehringer Ingelheim BioXcellence™

Boehringer Ingelheim and AnGes sign manufacturing agreement for HGF gene therapy product

[Read more](/content/partnering/boehringer-ingelheim-bioxcellence/hgf-gene-therapy-product "Read more about "Boehringer Ingelheim and AnGes sign manufacturing agreement for HGF gene therapy product""/index.html)

Boehringer Ingelheim enhances biopharmaceutical contract manufacturing services in China

[Read more](/content/partnering/boehringer-ingelheim-bioxcellence/biopharmaceutical-contract-manufacturing-services-china-enhanced "Read more about "Boehringer Ingelheim enhances biopharmaceutical contract manufacturing services in China""/index.html)

Frequently Asked Questions (FAQ) about Boehringer Ingelheim BioXcellence™

What is Boehringer Ingelheim BioXcellence™?

Boehringer Ingelheim BioXcellence™ is the biopharmaceutical contract manufacturing organization (CDMO) of Boehringer Ingelheim. It provides integrated CDMO services for biologics, supporting partners from late‑stage clinical supply through commercial production.

Which types of biologics does Boehringer Ingelheim BioXcellence™ produce?

Boehringer Ingelheim BioXcellence™ manufactures a wide range of biologics, including monoclonal and multi-specific antibodies, recombinant proteins and enzymes, antibody fragments, peptide hormones and plasmid DNA (pDNA), using both mammalian cell culture and microbial expression systems.

What manufacturing technologies does Boehringer Ingelheim BioXcellence™ offer?

Boehringer Ingelheim BioXcellence™ offers mammalian cell culture and microbial manufacturing technologies as well as aseptic filling services. Capabilities include upstream and downstream processing, process development, analytical services, technology transfer, cGMP manufacturing and batch release testing.

Where are Boehringer Ingelheim BioXcellence™ manufacturing sites located?

Boehringer Ingelheim BioXcellence™ operates a global network of biopharmaceutical manufacturing sites in Europe, the United States and Asia. All sites are licensed by major regulatory authorities and designed to support flexible supply.

How does Boehringer Ingelheim BioXcellence™ support technology transfer and scale‑up?

Boehringer Ingelheim BioXcellence™ uses structured, science‑based technology transfer approaches to support efficient scale‑up and knowledge transfer from development to GMP manufacturing. Experienced teams work collaboratively with partners to enable robust processes, smooth transitions and reliable long‑term production.

What differentiates Boehringer Ingelheim BioXcellence™ from other biopharmaceutical CDMOs?

Boehringer Ingelheim BioXcellence™ combines more than four decades of biopharmaceutical manufacturing experience with the resources and culture of an independent, privately held pharmaceutical company. We focus on high-quality standards, reliable execution and a collaborative, long-lasting partnership approach along the product life cycle. Our experienced teams show long‑term commitment and work transparently as well as proactively with partners to optimize biologics manufacturing success.

How can I contact Boehringer Ingelheim BioXcellence™?

You can reach the Boehringer Ingelheim BioXcellence™ team via the contact form on this website or by email at bioxcellence@boehringer-ingelheim.com. After submitting basic project information, an expert will follow up to discuss potential collaboration options.